HJF received an award for OMNIBUS IV, a multiple-award, indefinite-delivery/indefinite-quantity contract that will provide military medical research

HJF has donated $30,000 to Global Surgical and Medical Support Group (GSMSG) to support the Lviv Visiting Surgeon Program

To help service members make informed decisions about dietary supplement use, a new Department of Defense Instruction, DoDI 6130.06

2022 Hero of Military Medicine Ambassador Award Announcement

Military medical researchers have identified specific inherited, or “germline,” gene mutations associated with prostate cancer development specific to African American men.

Military medical researchers have identified specific inherited, or “germline,” gene mutations associated with prostate cancer development specific to African American men.

In a new article, researchers from the Center for Prostate Disease Research demonstrated a new method to treat drug-resistant prostate disease.

Volumetric muscle loss is frequently found in Service members with traumatic limb injuries.

CAMRIS International, LLC, an HJF Company, today announced its involvement in COVID-19 vaccine research by the Walter Reed Army Institute of Research.

Annabel Lee Raboy, MSW, received the Best Poster Presentation award during the inaugural Defense Intrepid Network Research Symposium.

In November USO San Diego | Camp Pendleton handed out the HJF MilKid Kits, jumpstarting discovery and experimentation for 200 future scientists.

HJF hosted a Leadership Roundtable with leaders from the private and military medical research communities.

HJF would like to remind everyone to stay safe this winter and encourages all who are able, to get a booster shot.

Andrea Lindsey, an HJF employee supporting the Consortium for Health and Military Performance (CHAMP) was asked about supplements.

HJF is supporting a study to expand specialized care across the military health system for military dependents.